Showing 18,181 - 18,200 results of 31,172 for search '(( 50 ((((we decrease) OR (a decrease))) OR (mean decrease)) ) OR ( 2 step decrease ))', query time: 0.99s Refine Results
  1. 18181

    Effect of CART on motor behavior. by Peizhong Mao (189608)

    Published 2012
    “…For the Control (CTL) group, there was nearly a 50/50 split in terms of the number of free versus wall-assisted rears. …”
  2. 18182

    Table_5_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
  3. 18183

    Table_2_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
  4. 18184

    Table_3_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
  5. 18185

    Table_1_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
  6. 18186

    Table_4_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
  7. 18187

    Table_6_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
  8. 18188

    Image_2_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.TIF by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
  9. 18189

    Image_1_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.TIFF by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
  10. 18190

    Table_7_Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection.xlsx by Michelle L. D'Antoni (8058620)

    Published 2019
    “…These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.…”
  11. 18191

    Global Consumption Trend of Antifungal Agents in Humans From 2008 to 2018: Data From 65 Middle- and High-Income Countries by Pathadka, Swathi

    Published 2022
    “…Results: Consumption of systemic antifungal agents increased from 0.50 (in 2008) to 0.92 defined daily dose (DDD)/1000 inhabitants/day (in 2018), with a compound annual growth rate of 6.2%. …”
    Get full text
    Get full text
    Get full text
  12. 18192

    DataSheet_1_E2F1 mediates competition, proliferation and response to cisplatin in cohabitating resistant and sensitive ovarian cancer cells.docx by Andres Valdivia (16546941)

    Published 2024
    “…Direct co-culture led to a decrease in the IC50 to platinum in the cisplatin-sensitive cells (5.92 µM to 2.79 µM for PE01, and from 2.05 µM to 1.51 µM for OVCAR5). …”
  13. 18193

    Data_Sheet_1_Large Gatherings? No, Thank You. Devaluation of Crowded Social Scenes During the COVID-19 Pandemic.pdf by Claudia Massaccesi (10898715)

    Published 2021
    “…Even people not directly affected by the virus itself were impacted in their physical and/or mental health, as well as in their financial security, by governmental lockdown measures. We investigated whether the combination of these events had changed people's appraisal of social scenes by testing 241 participants recruited mainly in Italy, Austria, and Germany in an online, preregistered study conducted about 50 days after the beginning of the COVID-19 outbreak in Europe. …”
  14. 18194

    Data_Sheet_1_Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies.pdf by Eli Hatchwell (8584452)

    Published 2022
    “…</p>Conclusion<p>For the first time, a PML genetic risk test can be implemented for screening patients taking or considering treatment with a PML-linked drug in order to decrease the incidence of PML and enable safer use of highly effective therapies used to treat their underlying disease.…”
  15. 18195
  16. 18196

    Low SGZ proliferation and neurogenesis in the dentate gyrus of adult <i>Prnp<sup>0/0</sup></i> mice correlate with high numbers of double labeled NG2-BrdU cells in the molecular la... by Ana Bribián (171285)

    Published 2012
    “…<p><b>A</b>) Left: Quantification of the number of PSA-NCAM-positive and BrdU-positive cells in dentate gyrus sections from <i>Prnp<sup>+/+</sup></i> and <i>Prnp<sup>0/0</sup></i> mice one day after BrdU-labeling. …”
  17. 18197
  18. 18198

    Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations by Mathew J. Barber (251595)

    Published 2010
    “…<div><h3>Background</h3><p>Statins effectively lower total and plasma LDL-cholesterol, but the magnitude of decrease varies among individuals. To identify single nucleotide polymorphisms (SNPs) contributing to this variation, we performed a combined analysis of genome-wide association (GWA) results from three trials of statin efficacy.…”
  19. 18199

    FIGURE 6 from Targeting <i>MALAT1</i> Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer by Anjali Yadav (17117308)

    Published 2023
    “…The IC<sub>50</sub> values were calculated by generating a dose–response curve using GraphPad Prism software. …”
  20. 18200